Luminus Management’s FibroBiologics FBLG Stock Holding History

Luminus Management’s Portfolio FBLG Stock Details FBLG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,331	Closed	-$346K	–	28
2025 Q3	$346K	Buy	+1,331	New	+$15.9K	0.31%	17

Other funds holding FBLG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CFP

Cascade Financial Partners San Diego, California $970M AUM 19.9% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

ANTB

AMG National Trust Bank Greenwood Village, Colorado $4.61B AUM 19.2% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Luminus Management's FBLG Position: Q4 2025 in Review

Luminus Management sold out of FibroBiologics (FBLG) in Q4 2025, closing a stake of 1,331 shares — an estimated $346K sold.

Luminus Management first reported a position in FBLG in Q3 2025 and held it in 1 quarter. The position peaked at $346K in Q3 2025. 45 funds tracked by Wall St. Rank hold FBLG as of Q4 2025.

Luminus Management reported no remaining FibroBiologics position as of Q4 2025 after selling out during the quarter.
Luminus Management sold 1,331 FibroBiologics shares in Q4 2025, an estimated $346K.
Luminus Management first reported a position in FibroBiologics in Q3 2025 and held it in 1 quarter.
Luminus Management's FibroBiologics position peaked at $346K in Q3 2025.
45 funds tracked by Wall St. Rank held FibroBiologics as of Q4 2025.

Based on Luminus Management's 13F filing for Q4 2025, filed 17 Feb 2026.